D. Boral Capital Reaffirms Buy Rating for CervoMed (NASDAQ:CRVO)
D. Boral Capital restated their buy rating on shares of CervoMed (NASDAQ:CRVO – Free Report) in a report published on Wednesday,Benzinga reports. D. Boral Capital currently has a $10.00 target price on the stock. Several other research firms have also weighed in on CRVO. Roth Capital raised CervoMed to a “strong-buy” rating in a research […]
D. Boral Capital restated their buy rating on shares of CervoMed (NASDAQ:CRVO – Free Report) in a report published on Wednesday,Benzinga reports. D. Boral Capital currently has a $10.00 target price on the stock. Several other research firms have also weighed in on CRVO. Roth Capital raised CervoMed to a “strong-buy” rating in a research […]
